• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,114.65 483.00
( 0.63%)
Global Indices
Nasdaq
48,208.69 277.76
(0.58%)
Dow Jones
6,845.97 42.16
(0.62%)
Hang Seng
55,958.99 -349.43
(-0.62%)
Nikkei 225
10,579.52 -29.36
(-0.28%)
Forex
USD-INR
92.44 -0.46
(-0.50%)
EUR-INR
107.96 0.52
(0.48%)
GBP-INR
124.05 0.88
(0.72%)
JPY-INR
0.58 0.00
(0.32%)

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
533573
INE901L01018
267.3488556
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
APLLTD
27.89
14153.53
EPS(TTM)
Face Value()
Div & Yield %
25.82
2
1.53
 

hikal ltd
IndiaMART shares rally on Nalanda Capital bulk deal buy
Jan 16,2026
According to exchange data, Nalanda India Equity Fund, managed by Nalanda Capital, acquired 11.18 lakh shares, representing a 1.86% stake, at Rs 2,110 per share.

In the same transaction, Small Cap World Fund, managed by Capital Group, sold 6.26 lakh shares, or a 1.04% stake, for Rs 132.17 crore at the same price. The fund held a 1.83% stake in the company at the end of the September quarter.

IndiaMART's promoters currently hold a 49.17% stake. The company's shareholding pattern for the December quarter is yet to be released.

IndiaMART is India's largest online B2B marketplace for business products and services.

On a consolidated basis, net profit of IndiaMART InterMESH declined 38.79% to Rs 82.70 crore while net sales rose 12.45% to Rs 391.00 crore in Q2 September 2025 over Q2 September 2024.